128 related articles for article (PubMed ID: 25430625)
1. Managing children with chronic myeloid leukaemia.
Baccarani M
Br J Haematol; 2015 Jun; 169(5):759-60. PubMed ID: 25430625
[No Abstract] [Full Text] [Related]
2. Managing children with chronic myeloid leukaemia--response to Baccarani.
Millot F; Suttorp M
Br J Haematol; 2015 Jun; 169(5):760-1. PubMed ID: 25573033
[No Abstract] [Full Text] [Related]
3. Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years.
de la Fuente J; Baruchel A; Biondi A; de Bont E; Dresse MF; Suttorp M; Millot F;
Br J Haematol; 2014 Oct; 167(1):33-47. PubMed ID: 24976289
[TBL] [Abstract][Full Text] [Related]
4. Another set of guidelines for chronic myeloid leukaemia.
Clark RE
Br J Haematol; 2020 Oct; 191(2):147-149. PubMed ID: 32712951
[No Abstract] [Full Text] [Related]
5. [Early monitoring of BCR-ABL transcript levels and cytogenetic in assessing the prognosis of chronic myeloid leukemia].
Huang Q; Zhang XY; Li Y; Wang XM
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(38):3049-53. PubMed ID: 24417926
[TBL] [Abstract][Full Text] [Related]
6. The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.
Gallipoli P; Clark RE; Byrne J; Apperley JF; Milojkovic D; Foroni L; Goldman JM; O'Brien S
Br J Haematol; 2022 Mar; 196(6):e55-e57. PubMed ID: 34993961
[No Abstract] [Full Text] [Related]
7. Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.
Hughes T; Branford S
Blood Rev; 2006 Jan; 20(1):29-41. PubMed ID: 16426942
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of early molecular response in chronic myeloid leukaemia patients treated with imatinib in a single real-world medical centre in a developing country.
Bee PC; Sekaran V; Ng RR; Kweh TY; Gan GG
Singapore Med J; 2017 Mar; 58(3):150-154. PubMed ID: 27029807
[TBL] [Abstract][Full Text] [Related]
9. Standardisation of molecular monitoring for chronic myeloid leukaemia.
Cross NC
Best Pract Res Clin Haematol; 2009 Sep; 22(3):355-65. PubMed ID: 19959086
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting haematological remission despite persistence of the Philadelphia-positive clone in an untreated chronic myeloid leukaemia patient.
Hilbe W; Sill H; Eisterer W; Lin F; Bechter O; Grünewald K; Thaler J
Acta Haematol; 1998; 100(2):101-3. PubMed ID: 9792944
[No Abstract] [Full Text] [Related]
11. BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib.
Maël H; Audrey B; Evelyne CB; Pierre-Yves D; Kaddour C; Gilles S; Arnaud P
Ann Hematol; 2017 Feb; 96(2):335-336. PubMed ID: 27761606
[No Abstract] [Full Text] [Related]
12. [Chronic myeloid leukemia. Diagnosis, development and prognosis].
Tanzer J
Rev Prat; 1988 Jun; 38(18):1210-6. PubMed ID: 3175491
[No Abstract] [Full Text] [Related]
13. Chronic myeloid leukaemia presenting with bilateral papilloedema.
Keh YS; Mathur S; Naqvi S; Shaunak S
Br J Hosp Med (Lond); 2021 Jan; 82(1):1. PubMed ID: 33512295
[No Abstract] [Full Text] [Related]
14. A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course.
De Matteis G; Veneri D; Aprili F; Benati M; Paviati E; Guidi GC; Pizzolo G; Tecchio C
Ann Hematol; 2013 Mar; 92(3):413-5. PubMed ID: 23053185
[No Abstract] [Full Text] [Related]
15. Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.
Müller MC; Gattermann N; Lahaye T; Deininger MW; Berndt A; Fruehauf S; Neubauer A; Fischer T; Hossfeld DK; Schneller F; Krause SW; Nerl C; Sayer HG; Ottmann OG; Waller C; Aulitzky W; le Coutre P; Freund M; Merx K; Paschka P; König H; Kreil S; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2003 Dec; 17(12):2392-400. PubMed ID: 14523462
[TBL] [Abstract][Full Text] [Related]
16. [Actual aspects of chronic myeloid leukemia].
Aguayo-González A; Tuna-Aguilar EJ
Rev Invest Clin; 2012; 64(2):192-8. PubMed ID: 22991781
[No Abstract] [Full Text] [Related]
17. Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA.
Bartley PA; Ross DM; Latham S; Martin-Harris MH; Budgen B; Wilczek V; Branford S; Hughes TP; Morley AA
Int J Lab Hematol; 2010 Dec; 32(6 Pt 1):e222-8. PubMed ID: 20491997
[TBL] [Abstract][Full Text] [Related]
18. Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology.
van Kooten Niekerk PB; Roug AS; Petersen CC; Ommen HB; Kjeldsen E; Bendix K; Nyvold CG; Nederby L; Hokland P
Br J Haematol; 2013 Jul; 162(1):141-4. PubMed ID: 23593974
[No Abstract] [Full Text] [Related]
19. Acute abdomen in a patient with chronic myeloid leukaemia.
Voppuru SR; Patkar S
Indian J Med Res; 2020 Nov; 152(Suppl 1):S134-S135. PubMed ID: 35345168
[No Abstract] [Full Text] [Related]
20. Successful maintenance of molecular remission in chronic myelogenous leukaemia during pregnancy with transition from imatinib to pegylated interferon.
Ellis M; Mills AK
Intern Med J; 2015 Mar; 45(3):358-9. PubMed ID: 25735582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
